Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Vasiliki Gkika"'
Publikováno v:
Clinics and Practice, Vol 13, Iss 5, Pp 1035-1042 (2023)
Tolvaptan, a selective vasopressin V2 receptor antagonist, is the first and only approved specific treatment for Autosomal-Dominant Polycystic Kidney Disease (ADPKD), and is used in current clinical practice. Real clinical data are missing. In this r
Externí odkaz:
https://doaj.org/article/88f345451cef4051b7134eab5eb54407
Autor:
Vasiliki Gkika, Michaela Louka, Stavros Fokas, Eirini Tigka, Angelos Drakopoulos, Niki Markou, Konstantina Kanellopoulou, Myrto Kostopoulou, Mihail Tsagkatakis, George Tsirpanlis
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS A small percentage of patients with autosomal dominant polycystic kidney disease (ADPKD) have no clear family history. The clinical course and prognosis of the disease in this subgroup of patients may be different. The present stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3f82849f4b77a43885e43948955edee
https://doi.org/10.1093/ndt/gfac061.003
https://doi.org/10.1093/ndt/gfac061.003
Autor:
Vasiliki Gkika, Michaela Louka, Stavros Fokas, Eirini Tigka, Angelos Drakopoulos, Niki Markou, Georgia Doumani, Myrto Kostopoulou, Mihail Tsagkatakis, George Tsirpanlis
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS The identification of possible risk factors for the progression of autosomal dominant polycystic kidney disease (ADPKD) is an emerging field, especially after the introduction of tolvaptan as the first disease-specific treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecfdb09bed51faf80989ea4646703111
https://doi.org/10.1093/ndt/gfac061.005
https://doi.org/10.1093/ndt/gfac061.005
Autor:
Vasiliki Gkika, Michaela Louka, Konstantina Kanellopoulou, Stavros Fokas, Eirini Tigka, Mihail Tsagkatakis, Myrto Kostopoulou, Anastasia Koutsogianni, Konstantinos Lymperopoulos, George Tsirpanlis
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Recent advances in the treatment of autosomal dominant polycystic kidney disease (ADPKD) highlight the interplay between the clinical and laboratory profile of the disease. This study aims to present the baseline characteristics o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77b8e12d5bf9495cf4f8b8190100a430
https://doi.org/10.1093/ndt/gfac061.002
https://doi.org/10.1093/ndt/gfac061.002
Autor:
Michaela Louka, Konstantinos Lymperopoulos, Vasiliki Gkika, Konstantina Kanellopoulou, George Tsirpanlis, Anastasia Koutsogianni, Stavros Fokas, Myrto Kostopoulou
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Recent advances in the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) highlight the interplay between the clinical and the laboratory profile of the disease. This study aims to present the baseline characteristi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a22f46d574f66a4a907461899cc32e2
https://doi.org/10.1093/ndt/gfaa142.p0040
https://doi.org/10.1093/ndt/gfaa142.p0040
Autor:
Myrto Kostopoulou, Vasiliki Gkika, Michaela Louka, Eirini Tigka, George Tsirpanlis, Stavros Fokas, Mihail Tsagkatakis, Angelos Drakopoulos
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims The identification of possible risk factors for the progression of Autosomal Dominant Polycystic Kidney Disease (ADPKD) is an emerging field especially after the introduction of the first disease-specific treatment. The present st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30944a10c58c0290f00c5a7e934fd4e0
https://doi.org/10.1093/ndt/gfaa142.p0034
https://doi.org/10.1093/ndt/gfaa142.p0034